ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 4 filers reported holding ARALEZ PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $576,000 | -76.7% | 1,644,583 | 0.0% | 0.02% | -76.5% |
| Q1 2018 | $2,467,000 | +5.7% | 1,644,583 | 0.0% | 0.08% | -7.6% |
| Q4 2017 | $2,335,000 | -38.0% | 1,644,583 | 0.0% | 0.09% | -45.9% |
| Q3 2017 | $3,766,000 | +69.6% | 1,644,583 | 0.0% | 0.17% | +44.1% |
| Q2 2017 | $2,220,000 | -36.9% | 1,644,583 | 0.0% | 0.12% | -13.2% |
| Q1 2017 | $3,519,000 | -51.5% | 1,644,583 | 0.0% | 0.14% | -54.4% |
| Q4 2016 | $7,253,000 | -9.1% | 1,644,583 | 0.0% | 0.30% | -19.7% |
| Q3 2016 | $7,976,000 | +47.0% | 1,644,583 | 0.0% | 0.37% | +74.2% |
| Q2 2016 | $5,427,000 | -7.0% | 1,644,583 | 0.0% | 0.21% | -14.5% |
| Q1 2016 | $5,838,000 | – | 1,644,583 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 2,680,140 | $11,820,000 | 7.87% |
| Tiger Legatus Capital Management, LLC | 1,985,000 | $8,754,000 | 3.24% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $12,507,000 | 2.96% |
| Healthcare Value Capital, LLC | 575,000 | $2,536,000 | 2.72% |
| Broadfin Capital, LLC | 4,791,590 | $21,131,000 | 2.35% |
| FNY Managed Accounts LLC | 73,983 | $326,265,000 | 2.19% |
| Elk Creek Partners, LLC | 2,196,055 | $9,685,000 | 0.65% |
| Bryn Mawr Capital Management, LLC | 107,492 | $474,000 | 0.48% |
| Par Capital Management | 6,400,000 | $28,224,000 | 0.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,644,583 | $7,253,000 | 0.30% |